Stay updated with breaking news from Vaxxas pty ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key. ....
American philanthropists are among the top philanthropists in the world. America’s wealthiest people are also the most generous givers in the country. ....
According to FMI’s most recent market research, the global microneedle drug delivery systems market is projected to grow at a compound annual growth rate (CAGR) of 6.6% between 2023 and 2033. The market is expected to grow to a valuation of US$ 768.9 million by 2023. It is projected that the valuation will reach US$. ....
SK Bioscience Co. Ltd. and Vaxxas Pty. Ltd. have entered into a joint development agreement that could revolutionize vaccines by developing a vaccine-delivery device combination product using Vaxxas’ high-density microarray patch (HD-MAP) coupled with SK Bioscience’s typhoid vaccine, Skytyphoid. ....
[238 Pages Report] Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The mark. ....